Literature DB >> 14646111

Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V.

Kyouhei Arita1, Hiroshi Hashimoto, Toshiyuki Shimizu, Michiyuki Yamada, Mamoru Sato.   

Abstract

Human peptidylarginine deiminase V (PAD V) is a post-translational enzyme that catalyzes the conversion of arginine residues in protein into citrulline residues in the presence of calcium ion. Crystals of PAD V have been grown at 293 K using polyethylene glycol monomethylether as a precipitant. Crystals diffracted beyond 2.7 A resolution at 100 K at the SPring-8 synchrotron-radiation source. The crystal belongs to space group C2, with unit-cell parameters a = 144.6, b = 60.4, c = 113.4 A, beta = 123.6 degrees. The asymmetric unit contains one molecule, with a V(M) of 2.56 A(3) Da(-1) and a solvent content of 56.1%. A full set of X-ray diffraction data was collected to 2.8 A resolution with a completeness of 97.5%. Heavy-atom derivatives have been successfully prepared and structure analysis is in progress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646111     DOI: 10.1107/s0907444903022741

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  8 in total

Review 1.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Authors:  Corey P Causey; Justin E Jones; Jessica L Slack; Daisuke Kamei; Larry E Jones; Venkataraman Subramanian; Bryan Knuckley; Pedram Ebrahimi; Alexander A Chumanevich; Yuan Luo; Hiroshi Hashimoto; Mamoru Sato; Lorne J Hofseth; Paul R Thompson
Journal:  J Med Chem       Date:  2011-09-16       Impact factor: 7.446

3.  Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.

Authors:  Kyouhei Arita; Toshiyuki Shimizu; Hiroshi Hashimoto; Yuji Hidaka; Michiyuki Yamada; Mamoru Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.

Authors:  Masaki Unno; Kenji Kizawa; Makiko Ishihara; Hidenari Takahara
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

Review 5.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

6.  Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

Authors:  Yuan Luo; Kyouhei Arita; Monica Bhatia; Bryan Knuckley; Young-Ho Lee; Michael R Stallcup; Mamoru Sato; Paul R Thompson
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

7.  High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach.

Authors:  Berthold Hoppe; Guido A Heymann; Farzaneh Tolou; Holger Kiesewetter; Thomas Doerner; Abdulgabar Salama
Journal:  J Mol Med (Berl)       Date:  2004-08-25       Impact factor: 4.599

Review 8.  Histone citrullination: a new target for tumors.

Authors:  Dongwei Zhu; Yue Zhang; Shengjun Wang
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.